Grape King Bio (TPE:1707) Dividend Payout Ratio: 1.89 (As of Mar. 2026) — 170% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
79 GF Score
Price NT$90.10
GF Value NT$138.97
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Grape King Bio Dividend Payout Ratio?

Grape King Bio TPE:1707 -0.44% 79 Dividend Payout Ratio is 1.89 as of Mar. 2026, which is 170% above its 10-year median of 0.70. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$138.97 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 450 Drug Manufacturers companies, Grape King Bio ranks worse than 84.44% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Grape King Bio's Dividend Payout Ratio for the months ended in Mar. 2026 was 1.89.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Grape King Bio Ltd is 0.81, which seems too high.

The historical rank and industry rank for Grape King Bio's Dividend Payout Ratio or its related term are showing as below:

TPE:1707' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.59   Med: 0.7   Max: 0.85
Current: 0.81

During the past 13 years, the highest Dividend Payout Ratio of Grape King Bio was 0.85. The lowest was 0.59. And the median was 0.70.

TPE:1707's Dividend Payout Ratio is ranked worse than
84.44% of 450 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs TPE:1707: 0.81

As of today (2026-08-23), the Dividend Yield % of Grape King Bio is 6.66%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Grape King Bio was 9.69%. The lowest was 2.03%. And the median was 3.82%.

Grape King Bio's Dividends per Share for the months ended in Mar. 2026 was NT$2.20.

During the past 12 months, Grape King Bio's average Dividends Per Share Growth Rate was -33.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 2.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Grape King Bio was 44.20% per year. The lowest was -2.10% per year. And the median was 8.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Grape King Bio (TPE:1707) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Grape King Bio Dividend Payout Ratio Related Terms

Grape King Bio Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Dividend Payout Ratio Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.62 0.71 0.71 0.85

Grape King Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 2.31 0.00 0.00 1.89

TPE:1707 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grape King Bio Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Grape King Bio's Dividend Payout Ratio falls into.


TPE:1707
79GF Score
Grape King Bio Ltd TPE:1707
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Grape King Bio's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=6.9/ 8.167
=0.84

Grape King Bio's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=2.2/ 1.167
=1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 1.89 mean?
Grape King Bio (TPE:1707) has a Dividend Payout Ratio of 1.89 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Grape King Bio and its competitors. This is 170% above median its historical median of 0.70. Over the past decade, Grape King Bio's Dividend Payout Ratio has ranged from 0.59 to 0.85. According to the industry distribution chart, Grape King Bio ranks #380 out of 450 companies in the Drug Manufacturers industry, placing it in the top 84.4%.
Is Grape King Bio's Dividend Payout Ratio too high?
Grape King Bio's current Dividend Payout Ratio of 1.89 is 170% above median its 10-year median of 0.70. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 0.85. The Drug Manufacturers industry median Dividend Payout Ratio is 0.37. Grape King Bio's value of 1.89 is 410.8% above this industry median. Based on the distribution chart, Grape King Bio ranks #380 out of 450 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Grape King Bio ranks #380 out of 450 companies for Dividend Payout Ratio. This places Grape King Bio in the lower half of its industry. The industry median Dividend Payout Ratio is 0.37. Grape King Bio's value of 1.89 is 410.8% above this benchmark. Historically, Grape King Bio's own Dividend Payout Ratio has ranged from 0.59 to 0.85 over the past decade. While the company's 10-year median is 0.70 vs. the industry median of 0.37, Grape King Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.37, based on 450 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grape King Bio's current Dividend Payout Ratio of 1.89 is 410.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Grape King Bio and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grape King Bio's current Dividend Payout Ratio is 1.89, which is 170% above median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$138.97, compared to a current price of NT$90.10 — trading 35.2% below its estimated fair value. The current Dividend Payout Ratio is 1.89, which is 170% above median its 10-year median of 0.70 and 410.8% above the Drug Manufacturers industry median of 0.37. Grape King Bio's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Dividend Payout Ratio is 1.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$90.10 is trading 35.2% below its estimated GF Value™ of NT$138.97. GuruFocus considers Grape King Bio to be Significantly Undervalued.

Key valuation signals for TPE:1707:

  • Dividend Payout Ratio: 1.89 (170% above median its 10-year median of 0.70)
  • GF Value™: NT$138.97 vs. price of NT$90.10 (35.2% below fair value)
  • GF Score™: 79/100 with 4 warning signs
  • Industry Position: 410.8% above the Drug Manufacturers median (#380 of 450)

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score

Get the complete analysis for TPE:1707

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.10
Price
NT$138.97
GF Value